Saadi Ryan H. → Tevogen Inc. TVGNW

Stake: — Shares: 61,709,567 Class: Common Stock, par value $0.0001 per share

Composite Decision Signal · AVOID (DILUTION / EXIT TRAP) Conviction Score: 24/100

Disqualifiers: ACTIVE_DILUTION_SHELF: Active 424B5 / S-3 shelf takedown within ±30d

Active Schedule 13D filer baseline
Material 8-K governance/transaction event (Item 5.02 / 1.01 / 2.01) within ±30d

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

2 transactions

2 buys · 0 sales · 0 awards/exercises

Issuer Cluster

4 13D/G filings on this issuer

3 other filings besides this one

Filer Track Record

3 filings by this filer

2 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 1.00

102,979 shares short · -33.9% vs prior

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-09-14	Saadi Ryan H.	director, officer, 10%+ owner	Award	8,000,000	—	—
2026-09-14	Desai Kirti	officer	Award	750,000	—	—

Other 13D/G Filings on Tevogen Inc.

Filed	Form	Filer	Stake	Shares
2026-09-16	SCHEDULE 13D/A	Desai Kirti	6.30%	992,983	view →
2026-09-16	SCHEDULE 13D/A	Saadi Ryan H.	—	11,709,567	view →
2026-07-14	SCHEDULE 13D/A	Saadi Ryan H.	59.70%	3,709,567	view →

Other Filings by Saadi Ryan H.

Filed	Form	Issuer	Stake	Shares
2026-09-16	SCHEDULE 13D/A	Tevogen Inc.	—	11,709,567	view →
2026-07-14	SCHEDULE 13D/A	Tevogen Bio Holdings Inc.	59.70%	3,709,567	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →